Idenix Pharmaceuticals Reports Clinical Data for HCV Drug Candidates – IDX719 and IDX184 – at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting

[at noodls] – CAMBRIDGE, Mass., Nov. 10, 2012 (GLOBE NEWSWIRE) — Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human … more

View todays social media effects on IDIX

View the latest stocks trending across Twitter. Click to view dashboard